Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Winter H, Hu H-M, Urba WJ, Fox BA (1999) Tumor regression after adoptive transfer of effector T cells is independent of perforin of Fas ligand (APO-1L/CD95L). J Immunol 163: 4462–4472
Winter H, Hu HM, McClain K, Urba WJ, Fox BA (2001) Immunotherapy of melanoma: a dichotomy in the requirement for IFN-g in vaccine-induced antitumor immunity versus adoptive immunotherapy. J Immunol 166: 7370–7380
Hu H-M, Urba WJ, Fox BA (1998) Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile. J Immunol 161: 3033–3041
Barth, RJ Jr, Mule JJ, Spiess PJ, Rosenberg SA (1991) Interferon-γ and tumor necrosis factor-a have a role in tumor regressions mediated by murine CD8+ tumor infiltrating lymphocytes. J Exp Med 173: 647–658
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Winter, H., Hu, H.M., van den Engel, N.K., Hatz, R.A., Fox, B.A., Schildberg, F.W. (2003). Die T-Zell Polarisierung (TH1/TH2) Tumorvakzin drainierender Lymphozyten korreliert mit der Immunogenität des Tumors. In: Menger, M.D., Haas, N.P., Neugebauer, E., Bauer, H. (eds) Chirurgisches Forum 2003 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19024-7_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-19024-7_32
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00659-6
Online ISBN: 978-3-642-19024-7
eBook Packages: Springer Book Archive